Latest Business Development News

Page 11 of 38
Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.
Ada Torres
Ada Torres
30 Apr 2026
Estrella Resources has initiated Timor-Leste’s inaugural hard rock mineral extraction at its Ira Miri manganese project, advancing towards full-scale mining and simultaneously progressing a major limestone resource at Werumata.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Battery Age Minerals delivered maiden drilling success at Austria’s Bleiberg project, expanded its Apex Germanium-Gallium footprint in Utah by 40%, and confirmed high-grade gold-silver mineralisation at Argentina’s El Aguila. The company also progressed germanium technology evaluations and appointed a new CEO.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Anatara Lifesciences delivered ambiguous mechanism of action results for its Anti-Obesity Project while reporting statistically significant weight management effects from compound AOC. The company plans a limited Phase 1 study but may delay it amid ongoing strategic discussions, with cash reserves tightening to $0.7 million.
Ada Torres
Ada Torres
29 Apr 2026
Orbital Corporation advances its UAV engine production and hybrid propulsion technology while managing a $0.5 million net cash outflow in Q1 2026, supported by a $43 million business pipeline and new international contracts.
Victor Sage
Victor Sage
29 Apr 2026
Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.
Ada Torres
Ada Torres
29 Apr 2026
Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.
Ada Torres
Ada Torres
29 Apr 2026
Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.
Ada Torres
Ada Torres
29 Apr 2026
Amplia Therapeutics reported mature ACCENT trial data showing improved survival and multiple complete responses with narmafotinib, alongside a GMP production milestone and CFO appointment.
Ada Torres
Ada Torres
28 Apr 2026
Xamble Group stabilised revenue at A$1.64 million in Q1 2026 while narrowing its group EBITDA loss slightly despite ramped-up technology spending. The company completed its acquisition of YouthsToday, tripling its influencer base and locking in three commercial contracts worth A$1.17 million.
Sophie Babbage
Sophie Babbage
28 Apr 2026
RLF AgTech has posted its strongest trading period with $18.3 million revenue year-to-date and positive EBITDA in March, driven by a strategic reset under new CEO Stuart Upton and a $4.5 million capital raise.
Ada Torres
Ada Torres
28 Apr 2026

Browse the archive

Full archive